Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Fludase – Experimental Antiviral Drug for Influenza

Drug (Brand / Generic)

Fludase (DAS181)

Company / Licensee

NexBio

Therapy Class

Anti-viral agent

Product Description

Recombinant sialidase fusion protein

Current Indication

Treatment of influenza

Market Sector

Anti-infectives

Development Status

Phase II
Expand

Go Top